β-sitosterol interacts with pneumolysin to prevent Streptococcus pneumoniae infection

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Li, Hongen ^a   Zhao, Xiaoran ^a   Wang, Jianfeng ^a   Dong, Yu ^b   Meng, Song ^a   Li, Rui ^a   Niu, Xiaodi ^a   Deng, Xuming ^a  

^a JILIN UNIVERSITY   (China)

^b INSTITUTE OF BIOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; CHOLESTEROL; GAMMA-SITOSTEROL; PLY PROTEIN, STREPTOCOCCUS PNEUMONIAE; SITOSTEROL DERIVATIVE; STREPTOLYSIN;

ANIMAL; BINDING SITE; C57BL MOUSE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; GENETICS; HEMOLYSIS; HUMAN; LUNG; MALE; METABOLISM; MICROBIOLOGY; MOLECULAR MODEL; PATHOGENICITY; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; SURFACE PLASMON RESONANCE;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BINDING SITES; CHOLESTEROL; HEMOLYSIS; HUMANS; LUNG; MALE; MICE, INBRED C57BL; MODELS, MOLECULAR; PNEUMOCOCCAL INFECTIONS; SITOSTEROLS; STREPTOCOCCUS PNEUMONIAE; STREPTOLYSINS; SURFACE PLASMON RESONANCE;

EID: 84949239284     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep17668     Document Type: Article

References (31)

1. Rudan, I. et al. Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries. J Glob Health 3, 010401 (2013).
2. Waterer,. G. W., Rello, J. & Wunderink, R. G. Management of community-acquired pneumonia in adults. Am J Respir Crit Care Med 183, 157-64 (2011).
3. Lock, R. A., Paton, J. C. & Hansman, D. Purification and immunological characterization of neuraminidase produced by Streptococcus pneumoniae. Microb Pathog 4, 33-43 (1988).
4. Feldman, C. et al. Pneumolysin induces the salient histologic features of pneumococcal infection in the rat lung in vivo. Am J Respir Cell Mol Biol 5, 416-23 (1991).
5. Rosenow, C. et al. Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae. Mol Microbiol 25, 819-29 (1997).
6. Sampson, J. S., O'Connor, S. P., Stinson, A. R., Tharpe, J. A. & Russell, H. Cloning and nucleotide sequence analysis of psaA, the Streptococcus pneumoniae gene encoding a 37-kilodalton protein homologous to previously reported Streptococcus sp. adhesins. Infect Immun 62, 319-24 (1994).
7. McDaniel, L. S., Sheffield, J. S., Delucchi, P. & Briles, D. E. PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type. Infect Immun 59, 222-8 (1991).
8. Paton, J. C. & Ferrante, A. Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin. Infect Immun 41, 1212-6 (1983).
9. Cockeran, R., Anderson, R. & Feldman, C. The role of pneumolysin in the pathogenesis of Streptococcus pneumoniae infection. Curr Opin Infect Dis 15, 235-9 (2002).
10. Hollingshead, S. K. & Briles, D. E. Streptococcus pneumoniae: new tools for an old pathogen. Curr Opin Microbiol 4, 71-7 (2001).
11. Orihuela, C. J., Gao, G., Francis, K. P., Yu, J. & Tuomanen, E. I. Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. J Infect Dis 190, 1661-9 (2004).
12. Garcia-Suarez Mdel, M. et al. The role of pneumolysin in mediating lung damage in a lethal pneumococcal pneumonia murine model. Respir Res 8, 3 (2007).
13. Rasko, D. A. & Sperandio, V. Anti-virulence strategies to combat bacteria-mediated disease. Nat Rev Drug Discov 9, 117-28 (2010).
14. Gilbert, R. J. et al. Studies on the structure and mechanism of a bacterial protein toxin by analytical ultracentrifugation and small-angle neutron scattering. J Mol Biol 293, 1145-60 (1999).
15. Gilbert, R. J. et al. Two structural transitions in membrane pore formation by pneumolysin, the pore-forming toxin of Streptococcus pneumoniae. Cell 97, 647-55 (1999).
16. Wang, J. et al. Fisetin Inhibits Listeria monocytogenes Virulence by Interfering With the Oligomerization of Listeriolysin O. J Infect Dis 211, 1376-87 (2015).
17. Lim, J. H. et al. Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections. Immunity 27, 349-60 (2007).
18. Farrand, A. J., LaChapelle, S., Hotze, E. M., Johnson, A. E. & Tweten, R. K. Only two amino acids are essential for cytolytic toxin recognition of cholesterol at the membrane surface. Proc Natl Acad Sci USA 107, 4341-6 (2010).
19. Liu, H. H. & Tomasz, A. Penicillin tolerance in multiply drug-resistant natural isolates of Streptococcus pneumoniae. J Infect Dis 152, 365-72 (1985).
20. McCullers, J. A., English, B. K. & Novak, R. Isolation and characterization of vancomycin-tolerant Streptococcus pneumoniae from the cerebrospinal fluid of a patient who developed recrudescent meningitis. J Infect Dis 181, 369-73 (2000).
21. Musher, D. M., Phan, H. M. & Baughn, R. E. Protection against bacteremic pneumococcal infection by antibody to pneumolysin. J Infect Dis 183, 827-30 (2001).
22. Howard, J. G., Wallace, K. R. & Wright, G. P. The inhibitory effects of cholesterol and related sterols on haemolysis by streptolysin O. Br J Exp Pathol 34, 174-80 (1953).
23. Nollmann, M., Gilbert, R., Mitchell, T., Sferrazza, M. & Byron, O. The role of cholesterol in the activity of pneumolysin, a bacterial protein toxin. Biophys J 86, 3141-51 (2004).
24. Rubins, J. B. et al. Distinct roles for pneumolysin's cytotoxic and complement activities in the pathogenesis of pneumococcal pneumonia. Am J Respir Crit Care Med 153, 1339-46 (1996).
25. Shepard, L. A. et al. Identification of a membrane-spanning domain of the thiol-activated pore-forming toxin Clostridium perfringens perfringolysin O: an alpha-helical to beta-sheet transition identified by fluorescence spectroscopy. Biochemistry 37, 14563-74 (1998).
26. Dong, J. et al. Oroxylin A inhibits hemolysis via hindering the self-assembly of alpha-hemolysin heptameric transmembrane pore. PLoS Comput Biol 9, e1002869 (2013).
27. Niu, X. D. et al. Molecular insight into the inhibition mechanism of cyrtominetin to alpha-hemolysin by molecular dynamics simulation. European Journal Of Medicinal Chemistry 62, 320-328 (2013).
28. Hou, T., Wang, J., Li, Y. & Wang, W. Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from docking. J Comput Chem 32, 866-77 (2011).
29. Salomon-Ferrer, R., Case, D. A. & Walker, R. C. An overview of the Amber biomolecular simulation package. An overview of the Amber biomolecular simulation package 3, 198-210 (2012).
30. Hou, T., Wang, J., Li, Y. & Wang, W. Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. J Chem Inf Model 51, 69-82 (2011).
31. Dessing, M. C., Florquin, S., Paton, J. C. & van der Poll, T. Toll-like receptor 2 contributes to antibacterial defence against pneumolysin-deficient pneumococci. Cell Microbiol 10, 237-46 (2008).